Showing results (631-640 of 744) with videos related to

Sort By:
Pageof 75
The Prostate|July 11, 2020
Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significanceHarsimar Kaur, Iryna Samarska, Jiayun Lu, et al.
CA: a Cancer Journal for Clinicians|June 9, 2016
Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemLysandra Voltaggio, Ashley Cimino-Mathews, Justin A Bishop, et al.
The American Journal of Surgical Pathology|December 18, 2014
Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsyCarlos L Morais, Jeong S Han, Jennifer Gordetsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2013
Rb loss is characteristic of prostatic small cell neuroendocrine carcinomaHsueh-Li Tan, Akshay Sood, Hameed A Rahimi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2020
Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinomaChen Yang, Robert S Cimera, Ruth Aryeequaye, et al.
Human Pathology|August 7, 2004
Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative imagesJeffrey D Seidman, Robert A Soslow, Russell Vang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 12, 2011
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomasAntoun Toubaji, Roula Albadine, Alan K Meeker, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome]Johannes Giedl, Peter J Wild, Robert Stoehr, et al.
Proteome Science|July 31, 2014
Automated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer lethalityMichail Shipitsin, Clayton Small, Eldar Giladi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 14, 2023
Quantitative Nuclear Grading: An Objective, Artificial Intelligence-Facilitated Foundation for Grading Noninvasive Papillary Urothelial CarcinomaAva Slotman, Minqi Xu, Katherine Lindale, et al.
Pageof 75